Study title: A 12 week randomized, double-blind, double-dummy, placebo controlled, parallel group study in adolescents and adults with persistent asthma comparing the safety and efficacy of two doses of formoterol fumarate b.i.d. administered from the multi-dose powder
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases | |||||
Brands: | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: FORMOTEROL | |||||
ATC code: R03AC14 | |||||
Document link: | |||||
Document date: | |||||
Study number: CFOR2580605 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |